GE HealthCare Technologies (GEHC) has been pushing deeper into artificial intelligence in cardiac care, leading Laza Medical's US$160 million Series B funding while rolling out new AI tools across its imaging and ultrasound platforms.
These product launches and the Laza Medical funding have landed during a strong upswing in GE HealthCare Technologies’ shares, with a 30 day share price return of 27.39% and a 90 day move of 14.78%. The 1 year total shareholder return of 13.00% and 3 year total shareholder return of 19.13% point to steadier long run progress from a more subdued year to date share price return, which is close to flat at 0.53% down at a last close of US$82.38.
Spot potential peers riding the same healthcare AI wave as GE HealthCare Technologies by scanning our curated list of 35 healthcare AI stocks.The question now is whether GE HealthCare Technologies’ recent surge reflects investors finally catching up with the earnings and AI product roll out, or if sentiment has simply sprinted ahead of what the current valuation supports.
Against a last close of $82.38, the most followed narrative for GE HealthCare Technologies points to a fair value of $86.80, based on a discount rate of 8.09% and expectations around its AI enabled product mix.
The main factor that has to go right is that AI enabled imaging, software and SaaS, together with the current wave of new imaging and diagnostics products, continue to translate into higher margin growth while the Patient Care Solutions review addresses that segment's operational and profit challenges.
See why 82 investors see GE HealthCare Technologies as 5% undervalued.
Result: Fair Value of $86.80 (UNDERVALUED)
Still, tariff pressures and ongoing operational problems in Patient Care Solutions could quickly flip the GE HealthCare Technologies undervaluation story on its head.
Find out about the key risks to this GE HealthCare Technologies narrative.
Mixed signals on GE HealthCare Technologies so far. If you want to move quickly and decide where you stand, start by weighing 3 key rewards and 1 important warning sign.
If GE HealthCare Technologies has sharpened your focus on quality, do not stop here. Broaden your watchlist now with targeted ideas built from the Simply Wall St Screener.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com